Archives third-rock-ventures

by in
Entry Author Date Location
With $229M Deal, Amicus Gets a New Drug And Perhaps a Voucher 08/31/15 New York
Constellation Pharma Plots IPO Run As Genentech Passes on Buyout Deal 08/24/15 Boston
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day 08/11/15 San Francisco
CRISPR Race Heats Up As Gates, Crossovers Put $120M Into Editas 08/10/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
Good Times Roll on for Biotech VCs As Clarus Bags New $500M Fund 06/09/15 Boston
Eleven Bio’s Shares Routed as Dry Eye Drug Flunks Phase 3 Test 05/18/15 Boston
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
With $46M Haul, MyoKardia Becomes Third Rock’s Latest IPO Prospect 04/30/15 San Francisco
Blueprint Medicines Bags $147M in Upsized IPO 04/29/15 Boston
Crossovers Arm Jounce With $56M For “Next Step” Immuno-Oncology 04/23/15 Boston
Dunsire, Forum Pharma Look Beyond Fidelity For Big Alzheimer’s Push 04/22/15 Boston
Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups 04/17/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech 04/02/15 San Francisco
Flagship Ventures Raises Sails for $537M Fund, Its Largest to Date 03/26/15 Boston
Alexion Deal in Hand, Blueprint Readies IPO Pitch 03/23/15 Boston
Ex-Alnylam Exec to Steer Warp Drive Bio; Verdine Shifts Roles 03/04/15 Boston
Blueprint Cuts $265M Alexion Deal With IPO in Sight 03/03/15 Boston
Genzyme Buys into Neuro Gene Therapies With $845M Voyager Pact 02/11/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
“Innovation at Biotech’s Epicenter,” Dec. 17: Check Out the Agenda 12/10/14 San Francisco
East Coast Biotech Roundup: Unum, RaNA, Maxwell, Biogen, & More 12/05/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Page 1 of 13 next page »